+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Medically-Induced Coma Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Anesthetics & Sedatives , Neuromuscular Blocking Agents , Analgesics ), By Supportive Technology (Mechanical Ventilators, Intracranial Pressure , Neurological Monitoring Systems ), By Indication (Traumatic Brain Injury , Refractory Status Epilepticus, Stroke & Intracerebral Hemorrhage, Refractory Intracranial Hypertension, Neurocritical Surgical Support), By End User (Intensive Care Units , Neurological Care Centers, General Hospitals, Trauma & Emergency Centers) Companies, and Country Forecast, 2021 to 2034

Global Medically-Induced Coma Market size is forecast to increase from $2.3 Billion in 2026 to $4.16 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007797
Pages: 222 Pages

Immunohematology Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Immunohematology Analyzers , Immunohematology Reagents , Consumables & Accessories), By Technology (Biochips, Gel Cards , Microplates, Erythrocyte-Magnetized Technology, PCR ), By Application (Blood Grouping & Typing , Antibody Screening & Identification, Cross-matching, Disease Screening), By End-User (Blood Banks, Diagnostic Laboratories, Hospitals, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Immunohematology Market size is forecast to increase from $2.07 Billion in 2026 to $2.92 Billion in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007796
Pages: 214 Pages

Immunoglobulin Products Market Size, Share and Growth Outlook, 2026: Analysis By Product Formulation (Liquid Immunoglobulin Products, Lyophilized ), By Source (Human Plasma-derived, Recombinant Immunoglobulins ), By Application Category (Neurological Disorders , Hematological Disorders , Infectious Diseases , Immunological Disorders ), By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Online Pharmacies & Mail-order Services) Companies, and Country Forecast, 2021 to 2034

Global Immunoglobulin Products Market size is forecast to increase from $20.04 Billion in 2026 to $43.9 Billion in 2034 at a CAGR of 10.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007795
Pages: 211 Pages

Immunoglobulin Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (IgG , IgA , IgM , IgE , IgD ), By Mode of Delivery (Intravenous Immunoglobulin , Subcutaneous Immunoglobulin , Intramuscular Immunoglobulin ), By Application (Primary Immunodeficiency Diseases , Chronic Inflammatory Demyelinating Polyneuropathy , Secondary Immunodeficiencies , Idiopathic Thrombocytopenic Purpura , Myasthenia Gravis, Multifocal Motor Neuropathy ), By End-User (Hospitals, Specialty Clinics, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Immunoglobulin Market size is forecast to increase from $19.54 Billion in 2026 to $31.86 Billion in 2034 at a CAGR of 6.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007794
Pages: 229 Pages

Immunogenomics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Consumables & Reagents, Sequencing Instruments & Hardware, Bioinformatics Software & Analysis Tools), By Technology Type (Next-Generation Sequencing , Polymerase Chain Reaction , Microarray Analysis, Single-Cell Genomic Sequencing), By Application Category (Research Applications , Clinical Applications , Infectious Diseases & Vaccine Development, Autoimmune & Chronic Inflammatory Disorders), By End-User (Academic & Government Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Molecular Diagnostic Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Immunogenomics Market size is forecast to increase from $7.21 Billion in 2026 to $11.58 Billion in 2034 at a CAGR of 6.1% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007793
Pages: 222 Pages

Immunofluorescence Assay Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents and Kits , Instruments , Consumables & Accessories), By Immunofluorescence Methodology (Direct Immunofluorescence, Indirect Immunofluorescence), By Application (Cancer Diagnostics and Oncology Research, Infectious Disease Screening, Autoimmune Diseases, Cardiovascular Pathology), By End-User (Hospital Laboratories, Commercial Reference Laboratories, Academic Medical Centers & Universities, Contract Research Organizations) Companies, and Country Forecast, 2021 to 2034

Global Immunofluorescence Assay Market size is forecast to increase from $4.85 Billion in 2026 to $7.5 Billion in 2034 at a CAGR of 5.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007792
Pages: 228 Pages

Immunodiagnostics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents & Consumables, Instruments , Software & Services), By Technology (Enzyme-Linked Immunosorbent Assay , Chemiluminescence Immunoassay , Fluorescent Immunoassay , Radioimmunoassay , Rapid Tests ), By Clinical Application (Infectious Diseases, Oncology & Endocrinology, Hepatitis & Retrovirus Screening, Autoimmunity Disorders, Cardiac Markers, Bone and Mineral Metabolism), By Test Location (Centralized Laboratory Testing, Point-of-Care ), By End-User (Hospitals & Health Systems, Independent Clinical Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies) Companies, and Country Forecast, 2021 to 2034

Global Immunodiagnostics Market size is forecast to increase from $25.35 Billion in 2026 to $42.27 Billion in 2034 at a CAGR of 6.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007791
Pages: 211 Pages

Immunoassay Market Size, Share and Growth Outlook, 2026: Analysis By Product & Service (Reagents & Kits, Analyzers & Instruments, Software & Services), By Technology (Chemiluminescence Immunoassay , Fluorescence Immunoassay , Enzyme-Linked Immunosorbent Assay , Radioimmunoassay , Lateral Flow Immunoassay ), By Specimen Type (Blood & Serum, Saliva, Urine, Cerebrospinal Fluid ), By Application (Infectious Disease Testing, Oncology & Cancer Markers, Cardiology & Cardiac Markers, Endocrinology & Hormone Testing, Autoimmune Disease Testing), By End-User (Hospitals, Reference Laboratories, Blood Banks, Pharmaceutical & CROs, Home Care) Companies, and Country Forecast, 2021 to 2034

Global Immunoassay Market size is forecast to increase from $33.11 Billion in 2026 to $49.67 Billion in 2034 at a CAGR of 5.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007790
Pages: 211 Pages

Immunoassay for Neurological Biomarkers Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Reagents & Kits, Instruments , Services & Software), By Technology (Enzyme-Linked Immunosorbent Assay , Chemiluminescence Immunoassay , Multiplex Assays, Single Molecule Detection ), By Biomarker Type (Amyloid-Beta , Tau Proteins , Neurofilament Light Chain , Alpha-Synuclein, Glial Fibrillary Acidic Protein ), By Application (Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, Traumatic Brain Injury ), By End-User (Diagnostic Laboratories, Biopharmaceutical Companies, Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Immunoassay for Neurological Biomarkers Market size is forecast to increase from $1.41 Billion in 2026 to $2.75 Billion in 2034 at a CAGR of 8.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007789
Pages: 229 Pages

Immunoassay Analyzers Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Chemiluminescence Immunoassay , Fluorescence Immunoassay , Enzyme-Linked Immunosorbent Assay , Radioimmunoassay , Multiplex & Microarray Analyzers), By Modality (Fully Automated Analyzers, Semi-Automated Analyzers, Point-of-Care ), By Purchase Mode (Outright Purchase, Reagent Rental ), By Application (Infectious Diseases, Endocrinology, Oncology, Cardiology, Therapeutic Drug Monitoring), By End-User (Hospitals & Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic & Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Immunoassay Analyzers Market size is forecast to increase from $7.82 Billion in 2026 to $10.95 Billion in 2034 at a CAGR of 4.3% between 2026 and 2034.

Published: June 2026
Report Code: VPA10007788
Pages: 211 Pages